M
Mohamed H. Aboumanei
Researcher at Egyptian Atomic Energy Authority
Publications - 15
Citations - 90
Mohamed H. Aboumanei is an academic researcher from Egyptian Atomic Energy Authority. The author has contributed to research in topics: Biodistribution & Chemistry. The author has an hindex of 4, co-authored 10 publications receiving 36 citations. Previous affiliations of Mohamed H. Aboumanei include Cairo University.
Papers
More filters
Journal ArticleDOI
Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking, 125I-radiolabeling and in vivo biodistribution studies.
TL;DR: Compatibility with injectable diluents, in vitro hemolytic studies and in vivo histopathological examination confirmed the safety of parenteral application of MPDME1 and proved that MPdME represents promising parenTERal delivery system capable of improving antineoplastic activity of MPd.
Journal ArticleDOI
Design and development of a proniosomal transdermal drug delivery system of caffeine for management of migraine: In vitro characterization, 131I-radiolabeling and in vivo biodistribution studies
TL;DR: The obtained results proved that, PNS-4 represents a promising transdermal drug delivery system capable of overcoming challenges facing oral delivery of caffeine.
Journal ArticleDOI
Formulation of chitosan coated nanoliposomes for the oral delivery of colistin sulfate: in vitro characterization, 99mTc-radiolabeling and in vivo biodistribution studies.
TL;DR: Chitosan-coated colistin nanoliposomes were obtained via thin-film evaporation and electrostatic deposition methods using either Span 60, Tween 65 or Tween 80 as surfactants with different cholesterol.
Journal ArticleDOI
125)I labeling of clomiphene and biodistribution studies for possible use as a model in breast cancer imaging.
I.T. Ibrahim,I.T. Ibrahim,M.T. El-Kolaly,M.T. El-Kolaly,Mohamed H. Aboumanei,Mohamed H. Aboumanei,Aly A. Abdelbary,Aly A. Abdelbary +7 more
TL;DR: Data revealed the localization of tracer in tumor tissue with high percent sufficient to use (125)I-clomiphene as a promising tool for the diagnosis of breast cancer.
Journal ArticleDOI
Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies
TL;DR: It is concluded that microemulsion could be used as i.t. injectable delivery vehicle to improve targeting and tumor retention of MPD.